Capstone Secures New Homebuilder Projects Adding Immediate Revenue and EBITDA Growth

Go back to Capstone Secures New Homebuilder Projects Adding Immediate Revenue and EBITDA Growth
Capstone Therapeutics Corp (NASDAQ: CAPS) Delayed: 0.18 -0.02 (10%)
Previous Close $0.20    52 Week High $0.15 
Open $0.17    52 Week Low $0.04 
Day High $0.19    P/E N/A 
Day Low $0.17    EPS $-0.27 
Volume 2,908,166